Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist

Compiled from ClinicalTrials.gov and CTIS registry records · Last verified 27 Sep 2026 · Editorial standards

At a glance

Asian Institute of Gastroenterology, India is the lead sponsor of 39 current clinical trials in our India register. 28 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Vonoprazan, Esomeprazole and Amikacin. The most-studied condition is GERD.

ClinicalTrials.gov trials by status

Recruiting2872%
Not yet open718%
Active, closed410%

Trials by phase

Not applicable2154%
Observational1436%
Phase 425%
Phase 313%
Phase 213%

Clinical trials sponsored by Asian Institute of Gastroenterology, India

39 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
A Randomized Controlled Trial Comparing Underwater Versus Conventional Preventive Coagulation for Intraprocedural Vessel Management During Peroral Endoscopic Myotomy NCT07575295 · Vessel Puncture Site Reaction	Observational	Recruiting	2026-02	India
Composite Index for Outcome Burden in Acute Cholangitis NCT07667166 · Acute Cholangitis, Biliary Drainage	Observational	Recruiting	2026-04	India
A Randomized, Three-Arm Study Comparing Vonaprazan 10 mg, Vonaprazan 20 mg, and Esomeprazole 40 mg for the Healing of LA Grade B or Higher Reflux Esophagitis at 8 Weeks NCT06953986 · GERD Drugs: Esomeprazole, Vonoprazan	Not applicable	Recruiting	2025-12	India
Pancreatic Enzyme Replacement in Acute Necrotizing Pancreatitis NCT07441824 · Acute Necrotizing Pancreatitis, Pancreatic Exocrine Insufficiency	Phase 3	Recruiting	2026-04	India
A Study to Evaluate Role of Inhaled Amikacin to Prevent Ventilator Associated Pneumonia in Patients With Cirrhosis NCT06808074 · Hepatic Encephalopathy, Cirrhosis, Ventilator Associated Pneumonia (VAP) Drug: Amikacin	Phase 4	Recruiting	2025-02	India
Comparative Assessment of Esophagitis in Cases With and Without Esophageal Motility Disorders: A Prospective Study NCT06835374 · Esophageal Diseases	Not applicable	Recruiting	2024-05	India
Prospective Comparison of the Carbon Footprint of EUS vs MRCP for Evaluation of Suspected Choledocholithiasis NCT07283185 · Choledocholithiasis	Observational	Recruiting	2025-12	India
Anti-Reflux Endoscopic Therapy Using Argon Plasma Coagulation (AREA) in Gastroesophageal Reflux Disease (GERD) Patients: A Single Center, Randomized, Sham, Controlled Trial (The AREA Study) NCT06641375 · GERD	Not applicable	Recruiting	2024-02	India
To Evaluate Early (2-Week) vs. Standard (4-Week) Metal Stent Removal Following Endoscopic Ultrasound Guided WON Drainage NCT07307248 · Walled Off Necrosis	Not applicable	Recruiting	2025-12	India
Vonoprazan Alone vs With Itopride for Functional Dyspepsia: The VIVA Trial NCT07731542 · ClinicalTrials.gov ↗ · Functioanl Dyspepsia Drug: Vonoprazan	Not applicable	Recruiting	2026-01	India
Application of Machine Learning Models to Reduce Need for Diagnostic EUS or MRCP in Patients With Intermediate Likelihood of Choledocholithiasis NCT06066372 · ClinicalTrials.gov ↗ · Choledocholithiasis	Observational	Recruiting	2023-10	India
Safety and Efficacy of Underwater Endoscopic Mucosal Resection for Type I Gastric Neuroendocrine Tumors Measuring 5-9 mm NCT07728292 · ClinicalTrials.gov ↗ · Stomach Neuroendocrine Neoplasm	Not applicable	Recruiting	2026-07	India
Neural Sensitisation and Neuropsychological Alterations in Painful Chronic Pancreatitis NCT07707609 · ClinicalTrials.gov ↗ · Chronic Pancreatitis, Pain Management	Observational	Recruiting	2026-01	India
Standard Versus Oesophago-gastric Junction Complex Myotomy for Treatment naïve Type 2 Achalasia Patients NCT06870630 · ClinicalTrials.gov ↗ · Esophageal Diseases	Not applicable	Recruiting	2023-11	India
A Single Center Evaluation of AI Enabled SureForm Robotic Stapler (SureformTM) Compared to Conventional Stapler for Colorectal Cancer Procedures NCT07371832 · ClinicalTrials.gov ↗ · Colorectal Cancer	Observational	Recruiting	2026-02	India
Prospective Evaluation of the Carbon Footprint and Clinical Utility of IBUS Compared to Colonoscopy and Enterography in UC and CD NCT07431983 · ClinicalTrials.gov ↗ · Ulcerative Colitis (UC), Crohns Disease	Observational	Recruiting	2026-03	India
Incidence of Splanchnic Venous Thrombosis in Acute Pancreatitis and it's Correlation With Severity of Pancreatitis NCT07322978 · ClinicalTrials.gov ↗ · Acute Pancreatitis	Observational	Recruiting	2025-02	India
Vonoprazan Evaluation Compared to Standard Triple Therapy in Helicobacter Pylori eRadication NCT06959368 · ClinicalTrials.gov ↗ · Helicobacter Pylori Infection	Phase 4	Recruiting	2025-03	India
Effect of Weight Loss From ESG Plus Lifestyle Changes vs. Lifestyle Changes Alone in Sleep Apnea Patients NCT07082608 · ClinicalTrials.gov ↗ · OSA - Obstructive Sleep Apnea	Not applicable	Recruiting	2025-08	India
Vonaprazan Versus Esomeprazole for Healing of LA Grade B or Higher Esophagitis After POEM NCT06955520 · ClinicalTrials.gov ↗ · GERD Drugs: Esomeprazole, Vonoprazan	Not applicable	Recruiting	2025-04	India
Safety, Efficacy and Tolerability of Bowel Preparation and Colonoscopy in Patient With CHD, CKD and CLD NCT06874036 · ClinicalTrials.gov ↗ · Colon Disease	Observational	Recruiting	2024-08	India
Regenerative Endoscopy in Refractory Perianal Crohn's Disease NCT07652632 · ClinicalTrials.gov ↗ · Crohn Disease (CD), Perianal Crohns Disease	Not applicable	Recruiting	2026-04	India
A COMBINATION OF RECTAL INDOMETHACIN AND COLD WATER EXPOSURE OF THE AMPULLA AFTER ERCP IS SUPERIOR TO RECTAL INDOMETHACIN ALONE IN REDUCING THE INCIDENCE OF POST-ERCP PANCREATITIS -RCT NCT07574970 · ClinicalTrials.gov ↗ · Pancreas Disease	Observational	Recruiting	2025-12	India
Normal Values of Ambulatory 24-hour Oesophageal pH-impedance Monitoring in an Indian Cohort of Participants NCT06928350 · ClinicalTrials.gov ↗ · GERD (Gastroesophageal Reflux Disease)	Observational	Recruiting	2025-04	India
A Study Comparing Transperineal Ultrasound, Magnetic Resonance Imaging, Endoscopic Ultrasound, and Examination Under Anesthesia to Detect and Classify Perianal Fistulas in Patients With Crohn's Disease or Fistulas of Unknown Cause NCT07794410 · ClinicalTrials.gov ↗ · Crohn Disease (CD), Cryptoglandular Perianal Fistula	Not applicable	Recruiting	2025-07	India
A Multicentre Observational Cross-Sectional Study of The Gastric Precancerous Epithelial Pathway Using High-Definition Endoscopy And Histopathology In India NCT07486518 · ClinicalTrials.gov ↗ · Gastric Adenocarcinoma, Early Gastric Cancer	Observational	Recruiting	2026-08	India
Hybrid Endoscopic Stricturotomy Plus Balloon Dilation Versus Stricturotomy Alone for Short Crohn's Disease Strictures NCT06958159 · ClinicalTrials.gov ↗ · Crohn Disease (CD)	Not applicable	Recruiting	2025-04	India
Comparing Diagnostic Accuracy of High-end Intestinal Ultrasound Versus Mid-end Ultrasound With Tandem Ileo-colonoscopy in Inflammatory Bowel Disease : a Paired, Validating Confirmatory Study NCT06938295 · ClinicalTrials.gov ↗ · Inflammatory Bowel Disease (IBD)	Not applicable	Recruiting	2024-09	India
Evaluate the Detection of Retained Gastric Contents and Assess Safety Using the Flower Capsule Endoscopy in Healthy Individuals and GLP-1 Receptor Agonist Users NCT06927401 · Endoscopy, Digestive System, GLP1-R-related Disease	Not applicable	Not yet open	2025-04	India
Personalized Education and Pain Response in Chronic Pancreatitis NCT04654377 · ClinicalTrials.gov ↗ · Chronic Pancreatitis, Pain Syndrome, Depression, Anxiety	Not applicable	Not yet open	2025-08	India
RESTOREGI Study: Regenerative Endoscopic Stromal Therapy: Outcomes and Risk Factor Evaluation in GI Fistulas NCT07661043 · ClinicalTrials.gov ↗ · Fistula, Regenerative Medicine, Stromal Vascular Fraction	Not applicable	Not yet open	2026-06	India
EUS-Guided ATI and SWE in Individuals With Normal FibroScan NCT07714941 · ClinicalTrials.gov ↗ · Non-hepatobiliary Indications	Observational	Not yet open	2026-08	India
Proteolytic Enzyme Fortified Protein Supplement in Chronic Pancreatitis. NCT06585735 · ClinicalTrials.gov ↗ · Chronic Pancreatitis, Malnutrition	Not applicable	Not yet open	2024-09	India
Ovary Syndrome for Efficient Diagnosis and Targeted Therapy NCT06102629 · ClinicalTrials.gov ↗ · Polycystic Ovary Syndrome	Not applicable	Not yet open	2023-11	India
Combination Therapy With Infliximab and Tofacitinib for Acute Severe Ulcerative Colitis - CINTO Trial NCT07297069 · ClinicalTrials.gov ↗ · Acute Severe Ulcerative Colitis Drugs: Infliximab, Tofacitinib	Phase 2	Not yet open	2026-01	India
Role of Intestinal Ultrasound in Treat to Target Strategy in the Management of Inflammatory Bowel Disease : the IUS-TTT Study NCT06534216 · Crohn Disease, Ulcerative Colitis	Observational	Active, closed	2024-04	India
The Use of MicroRNAs Dysregulation as Potential Biomarkers for Effective Diagnosis of Endometriosis NCT06168097 · Endometriosis	Not applicable	Active, closed	2023-11	India
Endoscopic Balloon Dilation Versus Endoscopic Stricturotomy for Short Crohn's Strictures NCT05521867 · ClinicalTrials.gov ↗ · Crohn Disease	Not applicable	Active, closed	2023-02	India
Biological Optimization Versus Standard Care in Post-POEM Achalasia Patients (BIO-POEM) NCT07620899 · ClinicalTrials.gov ↗ · Achalasia Cardia, GERD (Gastroesophageal Reflux Disease)	Not applicable	Active, closed	2026-05	India

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Drugs in Asian Institute of Gastroenterology, India trials

5 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

Vonoprazan3 Esomeprazole2 Amikacin1 Infliximab1 Tofacitinib1

Conditions in Asian Institute of Gastroenterology, India trials

46 conditions

GERD3Chronic Pancreatitis3Crohn Disease (CD)3 Crohn Disease2Esophageal Diseases2Choledocholithiasis2GERD (Gastroesophageal Reflux Disease)2Vessel Puncture Site Reaction1Ulcerative Colitis1Acute Cholangitis1Biliary Drainage1Endoscopy, Digestive System1GLP1-R-related Disease1Acute Necrotizing Pancreatitis1Pancreatic Exocrine Insufficiency1Hepatic Encephalopathy1Cirrhosis1Ventilator Associated Pneumonia (VAP)1Endometriosis1Walled Off Necrosis1Functioanl Dyspepsia1Pain Syndrome1Depression, Anxiety1Stomach Neuroendocrine Neoplasm1

By trial register

Register	Trials	Recruiting
Clinical trials in India	39	28

A trial with sites in more than one country appears in each of those registers.

Other sponsors in GERD

Sponsor	Trials
Changhua Christian Hospital	1

Sponsors with the most current trials registered for this condition.

Questions about Asian Institute of Gastroenterology, India trials

How many clinical trials does Asian Institute of Gastroenterology, India sponsor?

Asian Institute of Gastroenterology, India is the lead sponsor of 39 current trials on ClinicalTrials.gov in our India register, as of the registry sync on 27 September 2026. Completed and withdrawn studies are not counted.

Are Asian Institute of Gastroenterology, India trials recruiting?

Yes. 28 of its 39 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Asian Institute of Gastroenterology, India testing?

Its current trials name 5 drugs and biologicals as interventions. The most frequent are Vonoprazan (3), Esomeprazole (2), Amikacin (1), Infliximab (1) and Tofacitinib (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 27 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.

Asian Institute of Gastroenterology, India clinical trials